scispace - formally typeset
O

Olivier Bensaude

Researcher at École Normale Supérieure

Publications -  70
Citations -  5229

Olivier Bensaude is an academic researcher from École Normale Supérieure. The author has contributed to research in topics: RNA polymerase II & Transcription (biology). The author has an hindex of 34, co-authored 66 publications receiving 4925 citations. Previous affiliations of Olivier Bensaude include Centre national de la recherche scientifique & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes

TL;DR: It is reported that in human HeLa cells more than half of the P-TEFb is sequestered in larger complexes that also contain 7SK RNA, an abundant, small nuclear RNA of hitherto unknown function, which may contribute to an important feedback loop modulating the activity of RNA Pol II.
Journal ArticleDOI

Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor

TL;DR: An in vitro reconstitution of 7SK‐dependent HEXIM1 association to purified P‐TEFb and subsequent CDK9 inhibition is reported and it is proposed that the RNA‐binding domain of HexIM1 mediates its association with 7SK and that P‐ TEFb then enters the complex through association with H EXIM1.
Journal ArticleDOI

Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation

TL;DR: A panel of monoclonal antibodies is available that distinguishes between phosphorylated isoforms of RNA polymerase II's (RNAP II) largest subunit, and how global RNAP II phosphorylation changes are affected by the physiological context such as cell stress and embryonic development is discussed.
Journal ArticleDOI

In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin.

TL;DR: In murine fibroblasts exposure to alpha-amanitin triggered degradation of the RPB1 subunit, while other RNAPII subunits, RPB5 and RPB8, remained almost unaffected, in contrast to other inhibitors, such as actinomycin D or 5,6-dichloro-1-beta-D-ribofuranosyl-benzimidazole.